TY  - JOUR
U1  - Zeitschriftenartikel, wissenschaftlich - begutachtet (reviewed)
A1  - Limaye, Dnyanesh
A1  - Todi, K.
A1  - Shroff, J.
A1  - Ramaswamy, A.
A1  - Kulkarni, P.
A1  - Limaye, Vaidehi
A1  - Fortwengel, Gerhard
T1  - Cost-effectiveness Study of Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients From Mumbai, India
JF  - Current Therapeutic Research
N2  - Diabetes is fast gaining the status of a potential epidemic in India, with >62 million individuals currently diagnosed with the disease.1 India currently faces an uncertain future in relation to the potential burden that diabetes may impose on the country. An estimated US$ 2.2 billion would be needed to sufficiently treat all cases of type 2 diabetes mellitus (T2DM) in India.2 Many interventions can reduce the burden of this disease. However, health care resources are limited; thus, interventions for diabetes treatment should be prioritized.
KW  - antidiabetic
KW  - cost-effectiveness
KW  - diabetes mellitus
KW  - India
Y1  - 2016
UN  - https://nbn-resolving.org/urn:nbn:de:bsz:960-opus4-9151
U6  - https://doi.org/10.1016/j.curtheres.2016.05.006
DO  - https://doi.org/10.1016/j.curtheres.2016.05.006
VL  - 78
IS  - Supplement
SP  - S2
EP  - S3
ER  -